Top compounds associated with response to OR6N2


Feature Type Standardized
Nominal ANOVA
mRNA ceranib-2 CTRPv2 pan-cancer AAC -0.042 0.2
mRNA lapatinib GDSC1000 pan-cancer AAC -0.061 0.2
mRNA NVP-231 CTRPv2 pan-cancer AAC -0.041 0.2
mRNA JW-7-52-1 GDSC1000 pan-cancer AAC -0.066 0.2
mRNA CAY10576 CTRPv2 pan-cancer AAC -0.05 0.2
mRNA BRD-K84807411 CTRPv2 pan-cancer AAC -0.09 0.2
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.044 0.2
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.044 0.2
mRNA SB52334 GDSC1000 pan-cancer AAC 0.041 0.2
mRNA JNK Inhibitor VIII GDSC1000 pan-cancer AAC -0.043 0.2
Download CSV